Mechanisms and modulation of macrophage activation
- PMID: 2049039
Mechanisms and modulation of macrophage activation
Abstract
In the two decades following the discovery that macrophages can be activated by cytokines, there have been four major advances in our understanding of this phenomenon: (i) the identification of two biochemically defined, cytokine-inducible antimicrobial pathways, the enzymatic generation of superoxide and the enzymatic generation of nitric oxide; (ii) the identification of individual cytokines of known amino acid sequence capable of inducing these antimicrobial pathways and enhancing macrophage antimicrobial function; (iii) the demonstration of the utility of macrophage activating factors in the prevention and treatment of infectious diseases in man; and (iv) the discovery of the phenomenon of macrophage deactivation, together with the identification of several macrophage deactivating cytokines. This review briefly surveys each of these points, with emphasis on the regulation of production of the reactive oxygen intermediates and reactive nitrogen intermediates by two distinct but comparably suppressive cytokines, macrophage deactivation factor (MDF) and transforming growth factor-beta (TGF-beta).
Similar articles
-
Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.J Immunol. 1990 Aug 1;145(3):940-4. J Immunol. 1990. PMID: 2115549
-
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.J Immunol. 1988 Oct 1;141(7):2407-12. J Immunol. 1988. PMID: 3139757
-
Deactivation of macrophages by transforming growth factor-beta.Nature. 1988 Jul 21;334(6179):260-2. doi: 10.1038/334260a0. Nature. 1988. PMID: 3041283
-
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19. J Infect Dis. 2002. PMID: 11992286 Review.
-
Alternatively activated macrophages in protozoan infections.Curr Opin Immunol. 2007 Aug;19(4):454-9. doi: 10.1016/j.coi.2007.05.007. Epub 2007 Jul 12. Curr Opin Immunol. 2007. PMID: 17628461 Review.
Cited by
-
A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with Toll-like receptor 4 demonstrates inherent preconditioning behavior.Math Biosci. 2009 Jan;217(1):19-26. doi: 10.1016/j.mbs.2008.10.002. Epub 2008 Oct 11. Math Biosci. 2009. PMID: 18950647 Free PMC article.
-
Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.J Biomed Biotechnol. 2010;2010:683485. doi: 10.1155/2010/683485. Epub 2009 Dec 9. J Biomed Biotechnol. 2010. PMID: 20029630 Free PMC article.
-
STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3.Sci Rep. 2015 Aug 24;5:13414. doi: 10.1038/srep13414. Sci Rep. 2015. PMID: 26299368 Free PMC article.
-
Redox homeostasis in mycobacteria: the key to tuberculosis control?Expert Rev Mol Med. 2011 Dec 16;13:e39. doi: 10.1017/S1462399411002079. Expert Rev Mol Med. 2011. PMID: 22172201 Free PMC article. Review.
-
The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.Infect Immun. 2023 Apr 18;91(4):e0049022. doi: 10.1128/iai.00490-22. Epub 2023 Mar 14. Infect Immun. 2023. PMID: 36916933 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical